Articles by: STEVE MOORE
views
Flowtech Fluidpower – 2024 results, how confident really that it will “drive strong returns”?
Power, motion and control components and systems distributor Flowtech Fluidpower (FLO) has announced its results for the 2024 calendar year and that first quarter of 2025 trading has “been in line with our expectations following the work completed during 2024 to build a more stable and scalable platform for focused growth”. How does this compare to a currently further down from 49p share price?
views
PageGroup – Q1 2025 impacted by “economic conditions which remained challenging”, but surely those conditions are now set to get even more challenging!
Most recently writing on ‘specialist professional recruitment company’ PageGroup (PAGE), last month with its shares falling back towards 325p I questioned whether its 2024 results emphasising its dividend was “reflecting confidence in our strategy” and concluded that its latest performance didn’t bode well and to still avoid. So what of now a “First Quarter 2025 Trading Update”, and the shares currently further lower towards 250p in response?
views
Tissue Regenix – argues valuation “bears no resemblance to the prospects or the typical valuation”, but the other ‘strategic review’ participants don’t seem to concur…
‘Regenerative medical devices’ group Tissue Regenix (TRX) has issued a “Conclusion of Strategic Review & Offer Period”-titled announcement including that “the board believes the company's valuation is now at a level which bears no resemblance to the prospects or the typical valuation that a business in this sector would be ascribed”. So a value-creating conclusion to the strategic review and offer period then?
views
Calnex Solutions – “pleased to provide” trading update, how ‘pleasing’ though is it?…
Most recently writing on Calnex Solutions (CLX), describing itself as “a leading provider of test and measurement solutions for the global telecommunications and cloud computing markets”, in November, with the shares down towards 60p, I questioned how confident to be of “expects to close the year in line with current market expectations” as the macroeconomic uncertainties persist. The company today states that it “is pleased to provide an update on trading for the year to 31 March 2025 and the outlook for FY26”, so what of the latest update with the shares currently at 44p?
views
Gooch & Housego – expects trading “in line with management's previous expectations”, but what are those expectations?…
Photonic components and systems manufacturer Gooch & Housego (GHH) has issued a “Half Year Trading Update” including that “demand from the group's Aerospace & Defence and Life Sciences markets has been strong and revenues from the group's fibre optic products used in subsea data cable networks also grew” and that its “order book increased to £121.5 million… The level of enquiries for the group's products and services remains high”. So how does the performance and outlook compare to the valuation at a current 407p share price?
views
Directa Plus – notes 2024 loss with “positive start to FY2025”. How “positive” really though?…
Describing itself as “a leading producer and supplier of graphene-based products for use in consumer and industrial markets”, Directa Plus (DCTA) has issued a “Trading and Operational Update & Notice of Results” announcement commencing that “Q1 FY2025 has been robust, with revenues of approximately €2 million, up c. 40% from the same period in 2024” and also including its “current order book stands at approximately €7 million for FY2025, supported further by a good pipeline of opportunities”. So what of a share price, at 6.25p, still well down from 8p as recently as earlier this year?
views
MyCelx Technologies – “pleased to provide an update on its trading and business operations”. Er, really?…
‘The clean water and clean air technology company’ MyCelx Technologies (MYX) states that it “is pleased to provide an update on its trading and business operations”. What of this, with already down from above 37p early this year, the shares currently further lower at 24.3p in response?
views
EnSilica – as warned here, the recent contract agreement announcements were attempted ramptastic as it’s now a major (lack of) profit warning!
Most recently writing on EnSilica (ENSI), which describes itself as “a leading chip maker of mixed-signal Application Specific Integrated Circuits”, just two weeks ago with the shares up towards 40p I reviewed whether contract announcements were attempted ramptastic ahead of its end-May year-end and concluded to still avoid/sell. There has since been also a “$18m 7 Year Design and Supply ASIC Contract” announcement and the shares most recently closed at 39p, before now a “Trading Update”…
